Psilocybin therapy showed promise in treating mood dysfunction in people Parkinson's disease, a pilot trial suggested. ( ...

Colorado lawmakers are considering legislation that would charge the state health agency to collect data and information on ...

Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media ...

Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.

Discover how psilocybin therapy could transform Parkinson’s care - read more about this promising pilot trial and future ...

A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, ...

Ms. Pitman holds a B.Sc. in Microbiology from the University of New Hampshire and has been involved in the approval of several FDA-approved therapies, including QINLOCK® for gastrointestinal stromal ...

A UCSF pilot study finds psilocybin therapy surprises, showing meaningful improvements in mood, cognition, and motor symptoms ...

A recent study by researchers at the University of California, San Francisco (UCSF) has uncovered promising results from ...

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin ...